Blue Matter Blog

Alzheimer’s Disease: An In-Depth Look at a Formidable Foe
June 8, 2021

There is no shortage of disabling and deadly diseases in the world.  However, few match Alzheimer’s disease (AD) when it comes to sheer ability to cause fear and dread.  It’s not a rare disease.  In fact, it’s on the rise.  There is no cure (nor effective treatment yet) and it’s ultimately fatal.  And, most frightening, …

Recap:  Psychedelic Therapeutics and Drug Development Conference
May 25, 2021

Introduction Members of Blue Matter’s CNS team attended the Psychedelic Therapeutics & Drug Development Conference, a virtual event that took place May 4-6, 2021.  This event was particularly interesting to our team because we had just completed a white paper entitled “Taboo” Substances are Getting Another Look in CNS that explored the substances and companies …

American Academy of Neurology (AAN) 2021: Annual Meeting Recap
May 24, 2021

Introduction Members of our CNS team attended the American Academy of Neurology (AAN) virtual annual meeting, which took place April 17-22. As expected, it was an interesting and useful event, full of industry therapeutics updates, clinical research data, scientific sessions, and educational courses presented in a series of virtual panels, posters, and fireside chats.  It …

“Taboo” Substances Are Getting Another Look in CNS
March 22, 2021

Psychedelics and other traditionally taboo substances appear to be undergoing a bit of a “renaissance” in central nervous system (CNS) therapeutics these days.  These types of substances have a long and storied history all around the world.  Now, science is getting serious about exploring ways to use them to treat a range of diseases and …

Central Nervous System Therapies: Outlook for 2021 & Beyond
January 5, 2021

So far in this series, we’ve spent a great deal of time looking backward.  In part 1, we discussed the “quiet revolution” that has been taking place in CNS over the past several years.  Interesting advances are being made in a range of CNS therapies while other areas, such as oncology, tend to get more …

Central Nervous System Therapies: A Look at Rising Investment Activity
December 15, 2020

In Part 1 of this series, we said that a “quiet revolution” has been taking place in central nervous system (CNS) therapies.  While much attention has been focused on the dramatic advancements in oncology, companies large and small have been focusing more resources on CNS research, and the pace of advancement is accelerating.  In that …

Central Nervous System Therapies: Where We’ve Been and the Road Ahead
November 16, 2020

“Life moves pretty fast. If you don’t stop and look around once in a while, you could miss it.” Some readers might recognize that as a memorable line from the ‘80’s classic movie, Ferris Bueller’s Day Off.  Those same readers might also ask what it has to do with central nervous system (CNS) therapies. In …